# CUE-102 in Recurrent Glioblastoma

> **NCT06917885** · PHASE1 · RECRUITING · sponsor: **David Reardon, MD** · enrollment: 18 (estimated)

## Conditions studied

- Recurrent Glioblastoma
- Glioblastoma
- Glioma, Malignant

## Interventions

- **BIOLOGICAL:** CUE-102

## Key facts

- **NCT ID:** NCT06917885
- **Lead sponsor:** David Reardon, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-30
- **Primary completion:** 2027-01-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06917885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06917885, "CUE-102 in Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06917885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*